Callophycin A
Product Specifications
UNSPSC Description
Callophycin A, a red seaweed derived metabolite, possessing potent activity against Candida albicans with MIC of 62.5~250 mg/L. Callophycin A significantly reduces fungal burden of vaginal candidiasis induced mice, also decreases inflammatory response and immune molecules[1].
Target Antigen
Antibiotic; Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/callophycin-a.html
Solubility
10 mM in DMSO
Smiles
O=C(C1CC2=C(CN1CC3=CC=C(O)C=C3)NC4=C2C=CC=C4)O
Molecular Weight
322.36
References & Citations
[1]Arumugam Ganeshkumar, et al. New insight of red seaweed derived Callophycin A as an alternative strategy to treat drug resistance vaginal candidiasis. Bioorg Chem. 2020 Nov;104:104256.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-146190/Callophycin-A-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-146190/
Clinical Information
No Development Reported
CAS Number
1345674-93-2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6189012-01 0.1 mL
ATXN1 (Ataxin-1, Spinocerebellar Ataxia Type 1 Protein, ATX1, SCA1) (MaxLight 405)
Ask
View Details 
MBS6189012-02 5x 0.1 mL
ATXN1 (Ataxin-1, Spinocerebellar Ataxia Type 1 Protein, ATX1, SCA1) (MaxLight 405)
Ask
View Details 